Junlong Zhuang

1.7k total citations · 1 hit paper
53 papers, 1.1k citations indexed

About

Junlong Zhuang is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Junlong Zhuang has authored 53 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pulmonary and Respiratory Medicine, 13 papers in Molecular Biology and 12 papers in Surgery. Recurrent topics in Junlong Zhuang's work include Prostate Cancer Diagnosis and Treatment (26 papers), Prostate Cancer Treatment and Research (20 papers) and Bladder and Urothelial Cancer Treatments (8 papers). Junlong Zhuang is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (26 papers), Prostate Cancer Treatment and Research (20 papers) and Bladder and Urothelial Cancer Treatments (8 papers). Junlong Zhuang collaborates with scholars based in China, Italy and United States. Junlong Zhuang's co-authors include Hongqian Guo, Jun Yan, Ruimin Huang, Xiaojing Huang, Qun Lu, Lan Shen, Bing Shen, Xiaozhi Zhao, Xi Zheng and Dianzheng Zhang and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Junlong Zhuang

48 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cancer-Associated Fibroblast–Derived miR-146a-5p Generates a Niche That Promotes Bladder Cancer Stemness and Chemoresistance

2023 96 citations Junlong Zhuang, Lan Shen et al. Cancer Research profile →

Peers

Junlong Zhuang

PRM

ONCOL

SURGE

Xiuwu Pan China

Guanqun Li China

Vamsi Parimi United States

Feliksas Jankevičius Lithuania

Dimas Carolina Belisario Italy

Toshihiko Itesako Japan

Jinhuan Wei China

Giulia Bertolini Italy

Lei Cai China

Xi Guo China

Xiuwu Pan China

Junlong Zhuang

627 ×1.1

295 ×0.7

353 ×1.2

PRM

238 ×1.0

ONCOL

106 ×0.6

SURGE

Citations per year, relative to Junlong Zhuang Junlong Zhuang (= 1×) peers Xiuwu Pan

Countries citing papers authored by Junlong Zhuang

Since Specialization

Citations

This map shows the geographic impact of Junlong Zhuang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junlong Zhuang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junlong Zhuang more than expected).

Fields of papers citing papers by Junlong Zhuang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junlong Zhuang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junlong Zhuang. The network helps show where Junlong Zhuang may publish in the future.

Co-authorship network of co-authors of Junlong Zhuang

This figure shows the co-authorship network connecting the top 25 collaborators of Junlong Zhuang. A scholar is included among the top collaborators of Junlong Zhuang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junlong Zhuang. Junlong Zhuang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Xuyu, Feng Zhou, Shun Zhang, et al.. (2025). Neoadjuvant darolutamide plus androgen deprivation therapy for high-risk and locally advanced prostate cancer: a multicenter, open-label, single-arm, phase II trial. World Journal of Urology. 43(1). 58–58. 1 indexed citations

Yang, Hongbin, Junlong Zhuang, Ran Chen, et al.. (2025). Copper single-atom–based flexible aptamer biochip for simultaneous monitoring of bladder cancer-related bacteria. Microchimica Acta. 192(9). 602–602.

Zheng, Jiamin, et al.. (2025). Self-luminous nanoengineered bacteria with the sustained release of interleukin 2 as an in situ vaccine for enhanced cancer immunotherapy. Acta Biomaterialia. 197. 386–399. 1 indexed citations

Martini, Alberto, Junlong Zhuang, Paweł Rajwa, et al.. (2024). External validation of an algorithm to personalize nerve sparing approaches during robot-assisted radical prostatectomy in men with unilateral high-risk prostate cancer. Prostate Cancer and Prostatic Diseases. 28(1). 223–225. 1 indexed citations

Sorce, Gabriele, Armando Stabile, Francesco Pellegrino, et al.. (2024). The impact of mpMRI-targeted vs systematic biopsy on the risk of prostate cancer downgrading at final pathology. World Journal of Urology. 42(1). 248–248. 2 indexed citations

Wang, Binyu, Yao Fu, Mengxia Chen, et al.. (2024). The presence of intraductal carcinoma of prostate is a risk factor for poor pathologic response in men with high-risk prostate cancer receiving neoadjuvant therapy. Urologic Oncology Seminars and Original Investigations. 42(3). 67.e9–67.e15. 1 indexed citations

Pellegrino, Francesco, Elio Mazzone, Armando Stabile, et al.. (2023). Impact of the time elapsed between prostate biopsy and surgery on the accuracy of nomograms predicting lymph node invasion in patients with clinically localized prostate cancer. Urologic Oncology Seminars and Original Investigations. 41(9). 387.e17–387.e25. 3 indexed citations

Zhuang, Junlong, Lan Shen, Meiqian Li, et al.. (2023). Cancer-Associated Fibroblast–Derived miR-146a-5p Generates a Niche That Promotes Bladder Cancer Stemness and Chemoresistance. Cancer Research. 83(10). 1611–1627. 96 indexed citations breakdown →

Chen, Mengxia, et al.. (2023). The Association Between [⁶⁸Ga]PSMA PET/CT Response and Biochemical Progression in Patients with High-Risk Prostate Cancer Receiving Neoadjuvant Therapy. Journal of Nuclear Medicine. 64(10). 1550–1555. 6 indexed citations

10.

Calleris, Giorgio, Alessandro Marquis, Junlong Zhuang, et al.. (2023). Impact of operator expertise on transperineal free-hand mpMRI-fusion-targeted biopsies under local anaesthesia for prostate cancer diagnosis: a multicenter prospective learning curve. World Journal of Urology. 41(12). 3867–3876. 3 indexed citations

11.

Ding, Meng, Xiaozhi Zhao, Wenli Diao, et al.. (2022). Cancer-associated fibroblasts promote the stemness and progression of renal cell carcinoma via exosomal miR-181d-5p. Cell Death Discovery. 8(1). 439–439. 25 indexed citations

12.

Zhuang, Junlong, Yansheng Kan, Yuwen Wang, et al.. (2022). Machine Learning-Based Prediction of Pathological Upgrade From Combined Transperineal Systematic and MRI-Targeted Prostate Biopsy to Final Pathology: A Multicenter Retrospective Study. Frontiers in Oncology. 12. 785684–785684. 3 indexed citations

13.

Zhuang, Junlong, et al.. (2022). 175TiP A prospective phase II study to investigate the efficacy and safety of olaparib plus abiraterone and prednisone combination therapy in mHSPC patients with HRR gene mutation. Annals of Oncology. 33. S1502–S1502. 2 indexed citations

14.

Qin, Haixiang, Lei Yang, Mengxia Chen, et al.. (2022). circCYP24A1 promotes Docetaxel resistance in prostate Cancer by Upregulating ALDH1A3. Biomarker Research. 10(1). 48–48. 16 indexed citations

15.

Marra, Giancarlo, Junlong Zhuang, Giorgio Calleris, et al.. (2020). Transperineal freehand multiparametric MRI fusion targeted biopsies under local anaesthesia for prostate cancer diagnosis: a multicentre prospective study of 1014 cases. British Journal of Urology. 127(1). 122–130. 34 indexed citations

16.

Li, Weijian, Mengxia Chen, Jie Gao, et al.. (2020). Association of preoperative urethral parameters on magnetic resonance imaging and immediate recovery of continence following Retzius-sparing robot-assisted radical prostatectomy. Translational Andrology and Urology. 9(2). 501–509. 8 indexed citations

17.

Huang, Xiaojing, Hongwen Zhu, Junlong Zhuang, et al.. (2018). Wnt7a activates canonical Wnt signaling, promotes bladder cancer cell invasion, and is suppressed by miR-370-3p. Journal of Biological Chemistry. 293(18). 6693–6706. 91 indexed citations

18.

Lin, Tingsheng, Ahu Yuan, Xiaozhi Zhao, et al.. (2017). Self-assembled tumor-targeting hyaluronic acid nanoparticles for photothermal ablation in orthotopic bladder cancer. Acta Biomaterialia. 53. 427–438. 78 indexed citations

19.

Zhuang, Junlong, Lan Shen, Lin Yang, et al.. (2017). TGFβ1 Promotes Gemcitabine Resistance through Regulating the LncRNA-LET/NF90/miR-145 Signaling Axis in Bladder Cancer. Theranostics. 7(12). 3053–3067. 125 indexed citations

20.

Wang, Chen, Chao Gao, Junlong Zhuang, Chao Ding, & Yong Wang. (2012). A combined approach identifies three mRNAs that are down-regulated by microRNA-29b and promote invasion ability in the breast cancer cell line MCF-7. Journal of Cancer Research and Clinical Oncology. 138(12). 2127–2136. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact